Artigo Revisado por pares

The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice

2000; Elsevier BV; Volume: 387; Issue: 2 Linguagem: Inglês

10.1016/s0014-2999(99)00807-9

ISSN

1879-0712

Autores

Toshihiro Okamoto,

Tópico(s)

Toxin Mechanisms and Immunotoxins

Resumo

Fas ligand, which is a type II membrane protein, is a major inducer of apoptosis. The effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice was studied. Pretreatment of mice with glycyrrhizin (100, 200 and 400 mg/kg, i.p.) inhibited the anti-Fas antibody (150 microg/kg, i.v.)-induced elevation of plasma aminotransferase activity in a dose-dependent manner. CPP32 is a cystein protease and CPP32-like activity induced by anti-Fas antibody injection was inhibited by glycyrrhizin (200 mg/kg). However, the addition of glycyrrhizin (up to 10(-4) M) to a liver cytosol fraction isolated from mice treated with anti-Fas antibodies (150 microg/kg, i.v.) did not inhibit the CPP32-like activity in vitro. The present results clearly show that glycyrrhizin inhibited anti-Fas antibody-induced hepatitis by acting upstream of CPP32-like protease activation.

Referência(s)